Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2026-03-05 @ 4:27 PM
Study NCT ID:
NCT00583102
Status:
TERMINATED
Last Update Posted:
2018-01-05
First Post:
2007-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose Escalation Phase I/II Study of Lovastatin With High-Dose Cytarabine for Refractory or Relapsed AML
Sponsor:
University of Iowa
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-06
Start Date Type:
ACTUAL
Primary Completion Date:
2013-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06
Completion Date Type:
ACTUAL
First Submit Date:
2007-12-20
First Submit QC Date:
None
Study First Post Date:
2007-12-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-10-10
Results First Submit QC Date:
None
Results First Post Date:
2018-01-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-05
Last Update Post Date:
2018-01-05
Last Update Post Date Type:
ACTUAL